PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis

Abstract

Current evidence indicates that PTEN genetic mutation is associated with poor prognosis in glioma patients. However, this finding is derived from data in observational studies, potentially subject to selection bias, and hence well conducted, high-quality randomized controlled trials are warranted.